These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31521680)

  • 21. Practical approaches for the treatment of chronic heart failure: Frequently asked questions, overlooked points and controversial issues in current clinical practice.
    Çavuşoğlu Y; Altay H; Ekmekçi A; Eren M; Küçükoğlu MS; Nalbantgil S; Sarı İ; Selçuk T; Temizhan A; Ural D; Weinstein JM; Yeşilbursa D; Yılmaz MB; Zoghi M; Aydoğdu S; Kutlu M; Özer N; Şahin M; Tokgözoğlu L
    Anatol J Cardiol; 2015 Oct; 15 Suppl 2():1-60. PubMed ID: 26574641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort.
    Jochmann A; Scherr A; Jochmann DC; Miedinger D; Török SS; Chhajed PN; Tamm M; Leuppi JD
    Swiss Med Wkly; 2012; 142():w13567. PubMed ID: 22481636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.
    Yang IA; Brown JL; George J; Jenkins S; McDonald CF; McDonald VM; Phillips K; Smith BJ; Zwar NA; Dabscheck E
    Med J Aust; 2017 Nov; 207(10):436-442. PubMed ID: 29129177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
    Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M;
    S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic obstructive pulmonary disease--a treatable disease.
    Osthoff M; Jenkins C; Leuppi J
    Swiss Med Wkly; 2013; 143():w13777. PubMed ID: 23592218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Options for Stable Chronic Obstructive Pulmonary Disease: Current Recommendations and Unmet Needs.
    Yawn BP; Kim V
    Cleve Clin J Med; 2018 Feb; 85(2 Suppl 1):S28-S37. PubMed ID: 29494330
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm.
    Wilkie M; Finch S; Schembri S
    COPD; 2015; 12(5):582-90. PubMed ID: 25774769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
    Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
    Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchodilators: current and future.
    Cazzola M; Matera MG
    Clin Chest Med; 2014 Mar; 35(1):191-201. PubMed ID: 24507846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological treatment of stable COPD: need for a simplified approach.
    Hillas G; Papaporfyriou A; Dimakou K; Papaioannou AI
    Postgrad Med; 2020 Mar; 132(2):126-131. PubMed ID: 31852408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit?
    Currie GP; Lipworth BJ
    QJM; 2016 Aug; 109(8):505-12. PubMed ID: 26559079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic obstructive pulmonary disease on inpatients with heart failure. GESAIC study results].
    Recio-Iglesias J; Grau-Amorós J; Formiga F; Camafort-Babkowski M; Trullàs-Vila JC; Rodríguez A;
    Med Clin (Barc); 2010 Apr; 134(10):427-32. PubMed ID: 20149399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine.
    Contoli M; Corsico AG; Santus P; Di Marco F; Braido F; Rogliani P; Calzetta L; Scichilone N
    COPD; 2017 Dec; 14(6):641-647. PubMed ID: 29116901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of overlapping asthma-chronic obstructive pulmonary disease: Can guidelines contribute in an evidence-free zone?
    Reddel HK
    J Allergy Clin Immunol; 2015 Sep; 136(3):546-52. PubMed ID: 26343938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.
    Hirt MN; Muttardi A; Helms TM; van den Bussche H; Eschenhagen T
    Clin Res Cardiol; 2016 May; 105(5):441-50. PubMed ID: 26552905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
    Pandey A; Golwala H; DeVore AD; Lu D; Madden G; Bhatt DL; Schulte PJ; Heidenreich PA; Yancy CW; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2016 Aug; 4(8):649-61. PubMed ID: 27179827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.